METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway

Gastric cancer (GC) poses a significant threat to human health and remains a prevalent form of cancer. Despite clinical treatments, the prognosis for Gastric cancer patients is still unsatisfactory, largely due to the development of multidrug resistance. Oxaliplatin (OXA), a second-generation platin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Hong, Zhongshi, Song, Jintian, Zhong, Peilin, Lin, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562647/
https://www.ncbi.nlm.nih.gov/pubmed/37822880
http://dx.doi.org/10.3389/fphar.2023.1257410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562647/
https://www.ncbi.nlm.nih.gov/pubmed/37822880
http://dx.doi.org/10.3389/fphar.2023.1257410

Ejemplares similares